Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Microneedle Flu Vaccine Market from 2024 to 2025?

The market size for the microneedle flu vaccine has witnessed a significant surge in the past few years. The market is projected to further grow from $1.51 billion in 2024 to $1.67 billion in 2025, with a compound annual growth rate (CAGR) of 10.6%. Factors contributing to the growth during the historic period include an increase in the global impact of seasonal flu, higher awareness regarding the benefits of vaccination, governments focusing on enhancing immunization coverage, a growing preference for less invasive drug delivery methods, and initial clinical triumphs of microneedle vaccines in animal studies.

What Is the Projected Market Size of the Microneedle Flu Vaccine Market?

In the forthcoming years, the microneedle flu vaccine market is anticipated to experience substantial growth, increasing to $2.48 billion in 2029 with a compound annual growth rate (CAGR) of 10.4%. The advancement during the projected period can be credited to factors like pandemic preparedness initiatives broadening, growing preference for needle-less vaccination techniques, wider usage of microneedles for diseases other than influenza, surging demand for convenient vaccination options, and augmented manufacturing scalability of microneedle patches. Foreseen trends in the projection period include a move towards dissolvable microneedle technologies, an escalating focus on self-regulated vaccine models, the incorporation of microneedles into wearable health monitoring systems, increased clinical trials for microneedle-based flu vaccines, and the introduction of microneedle platforms for pediatric and elderly usages.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24322&type=smp

Who are the Major Competitors in the Microneedle Flu Vaccine Market Outlook?

Major companies operating in the microneedle flu vaccine market are Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Novartis AG, Becton Dickinson and Company (BD), AptarGroup, Corium International, CosMED Pharmaceutical Co. Ltd., Vaxxas, PharmaJet, Inovio Pharmaceuticals, Vaxess Technologies, FluGen Inc., Debiotech S.A., Micron Biomedical Inc., NanoPass Technologies Limited, Micropoint Technologies Pte Ltd., TSRL Inc., Verndari Inc., Microdermics Inc.

What Is Fueling Growth in the Microneedle Flu Vaccine Market?

The microneedle flu vaccine market is projected to grow owing to the rising incidence of needle phobia. This phobia refers to a profound dread or anxiety provoked by the sight, feeling, or expectation of needle-based procedures, often leading to avoidance of essential medical treatments. Elevated sensitivity and past negative experiences contribute to the spread of needle phobia, fostering long-term fear and avoidance. Microneedle flu vaccines provide an almost pain-free, minimally intrusive alternative that eliminates psychological impediments to vaccination and bolsters patient compliance. For example, data from the American Society for Clinical Pathology (ASCP), a professional membership organization based in the US, indicated in February 2025 that about 50% to 60% of children suffer from needle phobia, also referred to as trypanophobia. This fear is most prevalent in children aged 4 to 6 years old. Hence, the escalating incidence of needle phobia is steering the growth in the microneedle flu vaccine market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24322&type=smp

Which Microneedle Flu Vaccine Market Segments Are Growing the Fastest?

The microneedle flu vaccine market covered in this report is segmented –

1) By Product Type: Hollow Microneedle, Solid Microneedle, Coated Microneedle, Dissolving Microneedle

2) By Route Of Administration: Oral, Parenteral, Nasal

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By Application: Flu Vaccination, Seasonal Flu Prevention, Pediatric Vaccines, Elderly Vaccines

Subsegments:

1) By Hollow Microneedle: Single-Use Hollow Microneedles, Multiple-Use Hollow Microneedles, Polymer-Based Hollow Microneedles, Silicon-Based Hollow Microneedles

2) By Solid Microneedle: Metal Solid Microneedles, Silicon Solid Microneedles, Polymer Solid Microneedles, Glass Solid Microneedles

3) By Coated Microneedle: Drug-Coated Microneedles, Vaccine-Coated Microneedles, Biodegradable Coated Microneedles, Nano-Coated Microneedles

4) By Dissolving Microneedle: Fast-Dissolving Microneedles, Slow-Release Microneedles, Hydrogel-Based Dissolving Microneedles, Sugar-Based Dissolving Microneedles

Which Industry Trends Are Shaping the Future of the Microneedle Flu Vaccine Market?

Notable corporations in the microneedle flu vaccine market are directing their efforts towards investments aimed at speeding up the development of patch-based RNA vaccines. These actions contribute to preliminary research and encourage partnerships to progress more advanced methods of vaccine delivery. For example, in March 2024, the Biomedical Advanced Research and Development Authority (BARDA), an American government organization, pledged an investment of $50 million through the Patch Forward Prize to facilitate the progress of microneedle patch-oriented RNA vaccines targeting influenza and COVID-19. This approach is designed to drive innovation at the early stages by funding the development of concepts and moving combination goods to Phase I clinical trials. This encourages cooperation between vaccine manufacturers and patch creators. The programme aims to tackle technical and regulatory challenges, improve vaccine accessibility, and bolster the nation’s readiness to combat infectious diseases.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/microneedle-flu-vaccine-global-market-report

Which Countries Are Leading the Microneedle Flu Vaccine Market?

North America was the largest region in the microneedle flu vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microneedle flu vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/customise?id=24322&type=smp

This Report Delivers Insight On:

1. How big is the microneedle flu vaccine market, and how is it changing globally?

2. Who are the major companies in the microneedle flu vaccine market, and how are they performing?

3. What are the key opportunities and risks in the microneedle flu vaccine market right now?

4. Which products or customer segments are growing the most in the microneedle flu vaccine market?

5. What factors are helping or slowing down the growth of the microneedle flu vaccine market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model